There are no established guidelines for treating metabolic syndrome as a whole, so first-line intervention should focus on underlying risk factors. The following strategies are recommended: Although ...

Biologics, including GLP-1 analogs and PCSK9 inhibitors, are advancing treatment options for metabolic syndrome components like type 2 diabetes and dyslipidemia. GLP-1 receptor agonists improve ...

CLEVELAND, Ohio (Oct 21, 2025)—The prevalence of metabolic syndrome, a dangerous and potentially deadly condition, increases with menopause. That’s the result of decreasing estrogen that protects ...

Please provide your email address to receive an email when new articles are posted on . Natural menopause at an early age was tied to a 27% higher metabolic syndrome risk vs. menopause at age 50 years ...